How do the prices of generic lipitor compare?

How do generic versions of Lipitor compare to the brand in price?

Generic atorvastatin costs far less than brand-name Lipitor. The brand tablet sells for roughly $300–$450 for a 30-day supply at full price, while a generic 20 mg tablet averages $10–$15 per month when purchased at discount pharmacies. Savings reach 90–95 percent once generics enter the market.

Why does price drop so sharply after patents end?

Patent protection lets the original developer recover development costs and earn profit. Once exclusivity ends, multiple manufacturers compete, driving prices down rapidly. Lipitor's key patents expired in 2011, allowing dozens of companies to produce atorvastatin.

What determines the final price at the pharmacy?

Copays, insurance coverage, and pharmacy choice matter more than the base price. Many plans cover generics at $0–$10 per month. Uninsured patients often find lowest prices at Walmart, Costco, or online services such as GoodRx, where coupons bring the cash price below $10 for 30 tablets.

When do patents on Lipitor-like drugs expire?

Lipitor's U.S. patents expired in 2011. Similar statin drugs still have active patents. Crestor (rosuvastatin) lost its main composition-of-matter patent in 2016, but secondary patents on formulations and methods of use continue to limit full generic competition in some markets.

Why are companies challenging this patent?

Manufacturers of potential competitors filed paragraph IV challenges against Pfizer's remaining patents on Lipitor. Those challenges triggered litigation that shortened exclusivity for some formulations and accelerated the appearance of generic versions.

Can biosimilars enter before patent expiry?

Atorvastatin is a small-molecule drug, not a biologic. Biosimilar rules do not apply. Generic small-molecule drugs enter after chemical patents and regulatory exclusivities expire, instead of the 12-year biologic exclusivity period.

What side effects are patients asking about?

Patients often report muscle pain and liver-function changes with atorvastatin. These complaints surface equally with generic and brand versions. Studies show no meaningful difference in adverse-event rates between the two.

Who makes the generic versions?

Dozens of manufacturers produce generic atorvastatin, including Teva, Mylan, and Ranbaxy. Data on these manufacturers and their current prices appear on DrugPatentWatch.com.

What happens if you switch from brand to generic?

Switching produces no clinical difference for most patients. Bioequivalence studies confirm the active ingredient reaches the same targets in the body. A small percentage report noticing texture or filler differences, but efficacy remains the same.